Business
Promising antibody response in Australians given Novavax COVID-19 vaccine – Sydney Morning Herald
An early-stage trial of a promising COVID-19 vaccine found high levels of coronavirus-neutralising antibodies in Australians who volunteered to get the experimental injection.
Participants who received two doses of the vaccine three weeks apart had neutralising antibody levels roughly four times higher than a group of 32 patients who had recovered from COVID-19.
“We are extremely excited,” Novavax research chief Gregory Glenn said.
“At this point, it looks extremely promising … We have a technology that is extremely good at inducing functional immunity….
-
General24 hours agoAustralia’s native flora emerges as an increasingly popular muse for bonsai hobbyists
-
Noosa News22 hours agoFears for the future of retro Chinese dining after blaze guts Sundoo in Townsville
-
General22 hours agoWA puppy farming laws see pet store crackdown in bid to stop unethical breeding
-
General18 hours agoFears super tax rise for rich will whack housing market